| Patents for A61P 33 - Antiparasitic agents (21,787) |
|---|
| 08/09/2001 | WO2001057026A1 Compounds having antitumor activity: process for their preparation and pharmaceutical compositions containing them |
| 08/09/2001 | WO2001057008A1 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors |
| 08/09/2001 | WO2001056987A1 Tosylproline analogs as thymidylate synthase inhibitors |
| 08/09/2001 | WO2000073324A9 Modulation of gene expression in gastrointestinal inflammation |
| 08/09/2001 | WO2000070046A9 Secreted polypeptides and corresponding polynucleotides |
| 08/09/2001 | CA2399686A1 Methods and materials relating to cub domain polypeptides and polynucleotides |
| 08/09/2001 | CA2399649A1 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides |
| 08/09/2001 | CA2399644A1 Methods and materials relating to neurotrimin-like polypeptides and polynucleotides |
| 08/09/2001 | CA2398996A1 Compounds having antitumor activity: process for their preparation and pharmaceutical compositions containing them |
| 08/09/2001 | CA2398754A1 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors |
| 08/09/2001 | CA2398752A1 Tosylproline analogs as thymidylate synthase inhibitors |
| 08/08/2001 | EP1122261A2 13 and 14-membered antibacterial macrolides |
| 08/08/2001 | EP1121444A2 Protein kinase homologs |
| 08/08/2001 | EP1121419A1 Tnfr related gene 12 |
| 08/08/2001 | EP0824357B1 The use of epidermal growth factor as a gastrointestinal therapeutic agent |
| 08/08/2001 | CN1307586A Substituted cyclooctadepsipeptides |
| 08/08/2001 | CN1069169C Applying formulations containing glycols and/or glycerides |
| 08/07/2001 | US6271374 Stable crystalline (6S)- and (6R)-tetrahydrofolic acid |
| 08/07/2001 | US6271267 Compound to regulate the morphological transition of dimorphic candida |
| 08/07/2001 | CA2145242C Oral pharmaceutical preparation |
| 08/02/2001 | WO2001055158A1 Azalide antibiotic compositions |
| 08/02/2001 | WO2001054720A1 Pharmaceutical composition for immunomodulation and preparation of vaccines comprising an antigen and an immunogenic oligodeoxynucleotide and a polycationic polymer as adjuvants |
| 08/02/2001 | WO2001054667A1 Electrospun pharmaceutical compositions |
| 08/02/2001 | WO2001004305A3 Human proteins involved in detoxification |
| 08/02/2001 | US20010011124 Genetic engineering |
| 08/02/2001 | US20010010934 Polypeptides that regulate epithelial specific gene expression; hypoproliferative disorders; medical diagnosis |
| 08/02/2001 | US20010010913 Isolated polypeptide |
| 08/02/2001 | CA2396884A1 Pharmaceutical composition for immunomodulation and preparation of vaccines comprising an antigen and an immunogenic oligodeoxynucleotide and a polycationic polymer as adjuvants |
| 08/02/2001 | CA2396640A1 Electrospun pharmaceutical compositions |
| 08/01/2001 | EP1119630A1 Nucleic acid constructs for genetic immunisation |
| 08/01/2001 | EP1119559A1 3-phenyl-pyrones |
| 08/01/2001 | EP1119550A1 2-substituted heterocyclic sulfonamides |
| 08/01/2001 | EP1119256A1 Oral combination of lufenuron and nitenpyram against fleas |
| 08/01/2001 | CN1306439A Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens |
| 08/01/2001 | CN1305810A Antimalarial compound dihydroartemisinin |
| 08/01/2001 | CN1069033C Anti-parasite oral spray contg. evericin and ivermectin for sheep |
| 08/01/2001 | CN1069032C Antiparasitic medicine contg. avermectin/ivermectin for animals |
| 07/31/2001 | US6268509 Parasiticidal pyrazoles |
| 07/31/2001 | US6268379 Substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 07/26/2001 | WO2001053343A1 Human polynucleotides, polypeptides, and antibodies |
| 07/26/2001 | WO2001053276A1 Dihydrofolate reductase inhibitors |
| 07/26/2001 | WO2001052858A1 Tetracycline compounds for treatment of cryptosporidium parvum related disorders |
| 07/26/2001 | CA2397863A1 Tetracycline compounds for treatment of cryptosporidium parvum related disorders |
| 07/26/2001 | CA2395054A1 Human polynucleotides, polypeptides, and antibodies |
| 07/25/2001 | EP1118663A1 Nucleic acids encoding chemotaxis inhibitory polypeptides |
| 07/25/2001 | EP0876346B1 Antimalarial quinolin derivatives |
| 07/25/2001 | CN1305493A Novel cyclosporins |
| 07/25/2001 | CN1305464A Heterocyclic compounds and methods to treat cardiac failure and other disorders |
| 07/25/2001 | CN1304727A Injection containing evericin or ivermectin and using benzyl benzoate or nitrone as co-solvent |
| 07/24/2001 | US6265537 Thiodepsipeptides for combating endoparasites and a method for producing the same |
| 07/24/2001 | US6265434 Antiinflammatory agents |
| 07/24/2001 | US6264947 Genetic engineering; therapy for cancer, autoimmune diseases, reproduction, antiinflammatory agents |
| 07/24/2001 | US6264917 Targeted ultrasound contrast agents |
| 07/24/2001 | CA2097497C Control of parasitic nematodes |
| 07/19/2001 | WO2001051608A2 Hybrid cells obtainable from antigen presenting cells |
| 07/19/2001 | WO2001051512A2 Human and parasite orphan receptor proteins |
| 07/19/2001 | WO2001005969A3 Electron transfer proteins |
| 07/19/2001 | WO2000073324A3 Modulation of gene expression in gastrointestinal inflammation |
| 07/19/2001 | US20010008939 Also useful in treating viral infections; antiprotozoa (plasmodium) activity |
| 07/19/2001 | US20010008901 Nitrile derivatives that inhibit cathepsin K |
| 07/19/2001 | CA2823768A1 Hybrid cells |
| 07/19/2001 | CA2397053A1 Human and parasite orphan receptor proteins |
| 07/18/2001 | EP1115882A1 Production and use of antimicrobial agents |
| 07/18/2001 | EP1115849A2 Genes of the 1-desoxy-d-xylulose biosynthetic pathway |
| 07/18/2001 | EP1115720A2 Novel n-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them |
| 07/18/2001 | EP1115388A1 Use of organophosphorous compounds for producing medicaments for the therapeutic and prophylactic treatment of infections or as a fungicide, bactericide or herbicide for plants |
| 07/18/2001 | CN1304447A Treatment of parasitic diseases by inhibition of cysteine proteases of papain superfamily |
| 07/18/2001 | CN1304310A Semi-solid aqueous preparations for oral applications of toltrazuril sulphone |
| 07/18/2001 | CN1068518C Wettable powder of niclosamide salt |
| 07/17/2001 | US6261544 Poly(hydroxy acid)/polymer conjugates for skin applications |
| 07/12/2001 | WO2001049821A2 Th1 specific cd4 t cell lines and method for inducing them ex vivo |
| 07/12/2001 | WO2001049711A2 Nucleic acids encoding (poly)peptides having chips activity |
| 07/12/2001 | WO2001049698A1 Cytotoxic agents comprising modified doxorubicins and daunorubicins and their therapeutic use |
| 07/12/2001 | WO2001049684A1 Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same |
| 07/12/2001 | WO2001049305A2 Process for obtaining thylakoids from plants, pure thylakoids and use thereof |
| 07/12/2001 | WO2001049303A1 Multivalent electron active compositions and methods of making and using same |
| 07/12/2001 | WO2001049302A1 Compositions and methods for facilitating skin growth and managing skin conditions |
| 07/12/2001 | WO2001049301A1 Methods of using electron active compounds for managing cancer |
| 07/12/2001 | WO2001049288A1 Novel compounds and compositions as protease inhibitors |
| 07/12/2001 | WO2001049279A2 Use of steroidal alkaloids to reverse multidrug resistance |
| 07/12/2001 | WO2001049278A2 Compounds and compositions for use in inhibiting endoparasitic fatty acid biosynthesis |
| 07/12/2001 | WO2001049269A1 Sustained-releasing anthelmintic compositions comprising praziquantel |
| 07/12/2001 | WO2001007087A8 Enzyme catalyzed anti-infective therapeutic agents |
| 07/12/2001 | WO2001004281A3 Dna coding for beta-tubulin and use thereof |
| 07/12/2001 | CA2396257A1 Novel compounds and compositions as protease inhibitors |
| 07/12/2001 | CA2396234A1 Compounds and compositions for use in inhibiting endoparasitic fatty acid biosynthesis |
| 07/12/2001 | CA2395876A1 Nucleic acids encoding (poly)peptides having chips activity |
| 07/12/2001 | CA2395660A1 Cytotoxic agents comprising modified doxorubicins and daunorubicins and their therapeutic use |
| 07/12/2001 | CA2395642A1 Use of steroidal alkaloids to reverse multidrug resistance |
| 07/11/2001 | EP1114826A2 Novel antibacterial and prokinetic macrolides |
| 07/11/2001 | EP1114159A1 Methods and compositions relating to egf-repeat-containing polypeptides |
| 07/11/2001 | EP1114158A2 Human cytoskeleton associated proteins |
| 07/11/2001 | EP1114146A2 Human serine/threonine protein kinases |
| 07/11/2001 | EP1113818A1 METHODS OF TREATING IgE-ASSOCIATED DISORDERS AND COMPOSITIONS FOR USE THEREIN |
| 07/11/2001 | EP1113815A1 Immunogenic compositions and uses thereof |
| 07/11/2001 | EP1113806A1 Anionic or cationic dendrimer antimicrobial or antiparasitic compositions |
| 07/11/2001 | CN1068224C External protection medicine for preventing schistosoma miracidium infection |
| 07/10/2001 | US6258952 Thermally stable trimetrexates and processes for producing the same |
| 07/10/2001 | US6258833 Enzyme inhibitors and antiinflammatory agents |
| 07/10/2001 | US6258562 Human antibodies that bind human TNFα |